Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

How Companies in Singapore Can Source Pharma Products & CDMO Services (2026 Guide)

Singapore • Source Pharma Products & CDMO Services

Mitul Agarwal
Written by Mitul Agarwal · B.Pharm, MBA
Founder & Head of Business Development · 25+ years in international pharmaceutical BD&L
Published 4 December 2025 · Reviewed and updated 21 October 2026
How Companies in Singapore Can Source Pharma Products & CDMO Services (2026 Guide)

Introduction

Singapore is a small market by volume but an important one. Its hospitals and clinics expect high-quality specialty medicines, its regulator is one of the most respected in Asia, and many companies use it as a regional base for distribution across Southeast Asia.

Because the bar is high, Singapore buyers tend to look for suppliers with strong regulatory track records, complete dossiers and reliable cold chain. This guide explains where supply typically comes from, how to qualify a manufacturer or CDMO, the import licences you need from the Health Sciences Authority (HSA), and the problems that most often slow projects down.

Where supply comes from

Singapore draws on a broad global supply base:

Supply baseWhat it is typically used for
Europe (EU-GMP) and the United StatesOriginator and specialty products, biologics, vaccines, sterile injectables and oncology
India and ChinaGeneric APIs and finished generics, including many products already approved in strict markets
Japan, South Korea and AustraliaBiosimilars, advanced formulations and high-quality generics
ASEAN neighbours (Malaysia, Thailand, Indonesia, Vietnam)Regional finished products, OTC and health supplements, and contract packaging

Singapore also hosts its own manufacturing of APIs and biologics, mainly for export. For generics, buyers often prefer sites that already supply regulated markets, because HSA's abridged and verification routes can rely on approvals from reference regulators.

Pharma categories supply

Specialty and hospital medicines

Oncology products, biologics and biosimilars, immunosuppressants, sterile injectables and anti-infectives for public hospitals and private specialist care.

Generics for chronic care

  • Cardiovascular, antidiabetic and lipid-lowering products
  • Gastrointestinal and respiratory medicines
  • Antibiotics such as azithromycin, ceftriaxone and amoxicillin

APIs and regional supply

Traders and regional hubs buy APIs and finished products for re-export to other ASEAN markets, which requires its own licensing.

Health supplements and CDMO work

Local brands contract private-label vitamins, supplements and OTC products, and use CDMOs for formulation development, clinical trial supply and contract packaging.

How to source pharma products

  1. Define the requirement. Product, strength, dosage form, pack size, annual volume, and whether it is for local supply, clinical trials or re-export.
  2. Check registration status. Find out whether the product is already on the Singapore Register of Therapeutic Products and who the registrant is. If not, decide who will file.
  3. Shortlist and verify suppliers. Singapore is a PIC/S member, so HSA expects GMP evidence at PIC/S-equivalent level. Check certificates against official databases using our supplier verification guide.
  4. Review the technical file. Ask for a dossier in ICH CTD or ACTD format, Zone IVB stability data, CoA, COPP and, for APIs, a DMF or CEP.
  5. Audit where needed. For sterile products and CDMO projects, a remote or on-site audit is common.
  6. Agree terms. MOQ, English artwork, lead time, Incoterms, cold chain responsibilities and payment terms.

PharmaTradz works with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. Post a requirement on the RFQ page to compare qualified offers.

Required documents for import

DocumentWhy it is needed
HSA importer's licence (and wholesaler's licence if you distribute)Required to import and supply therapeutic products
Product registration or registrant's authorisation letterShows the product is registered, or that the registrant authorises your imports
Import permit through TradeNetCustoms declaration for each shipment
Commercial invoice and packing listValuation and cargo check
Bill of lading or air waybillProof of shipment
Certificate of Analysis (CoA)Batch quality confirmation
GMP certificate and COPPEvidence of site and product compliance
Temperature recordsFor cold-chain goods, to support GDP compliance

Logistics and shipping

Main entry points

  • Air: Singapore Changi Airport, which has dedicated temperature-controlled cargo handling and is the main route for high-value and cold-chain medicines
  • Sea: Port of Singapore, through the Pasir Panjang and Tuas terminals

Indicative transit

Air freight from Asian and European hubs typically takes 1–4 days. Sea freight from South or East Asia typically takes 1–2 weeks, and from Europe typically 3–5 weeks.

Cold chain and terms

Biologics, vaccines and many injectables need 2–8°C or frozen handling with validated packaging and data loggers. CIP or DAP are common for finished products, so the supplier manages the cold chain up to arrival. Our GDP guide explains what to check in a distribution partner.

Customs

Import permits are filed through TradeNet with Singapore Customs, and GST is payable on imports. Goods imported only for re-export still need the right HSA licence.

Common challenges and practical solutions

ChallengePractical solution
HSA queries on the dossierChoose suppliers with reference-agency approvals and a complete CTD or ACTD file in English.
GDP audit findings before licensingSet up SOPs, temperature mapping and supplier qualification before applying.
Small volumes and high MOQsCombine Singapore supply with regional re-export volumes, or use small-batch manufacturers.
Cold-chain risk on long routesUse GDP-qualified forwarders, validated packaging and data loggers on every shipment.
Registrant and importer are different companiesGet a written authorisation letter and a clear quality agreement before the first order.

Conclusion

Singapore rewards preparation. A supplier with strong GMP evidence, a dossier in the right format and reliable cold chain will move through HSA review and licensing far more smoothly. Draw on EU-GMP and US sources for specialty and biologic products, and on qualified Asian manufacturers for generics and APIs.

PharmaTradz connects Singapore buyers with GMP-certified manufacturers and CDMOs across Asia, Europe, the Americas and Africa. Visit our Singapore country hub for more market information.

Frequently Asked Questions

Who can register a therapeutic product with HSA?

The registrant must be a local company in Singapore. Foreign manufacturers usually appoint a local registrant or set up their own entity.

Do I need an importer's licence to bring medicines into Singapore?

Yes. Importing therapeutic products requires an HSA importer's licence, and distributing them requires a wholesaler's licence. Both are applied for through PRISM.

Is GDP compliance mandatory for Singapore importers?

Yes. HSA audits importers and wholesalers against GDP standards before issuing a licence, except for a few restricted activities such as import only for export.

Which dossier formats does HSA accept?

HSA accepts dossiers in ICH CTD or ACTD format.

Can unregistered medicines be imported for a patient?

Yes, through HSA's special access routes, usually by a doctor or hospital, when no suitable registered product exists.

What language must labels be in?

English, for both the label and the package insert.

Source Pharma Products & CDMO Services — other markets

Disclaimer: The information presented in this article is for informational and educational purposes only. While every effort has been made to ensure data accuracy and reliability, readers are advised to independently verify all figures, regulations, and market insights before making any business or investment decisions.

Planning to register or source in Singapore?

Tell us the molecule, dosage form and target market. We will come back on the regulatory pathway and whether the project is realistic before you commit anything.

Submit a Requirement Ask a question
Are you a manufacturer rather than a buyer?
If you already hold WHO-GMP, EU-GMP, USFDA or PIC/S approval, you are closer to supplying Singapore than you probably think.
Supply LATAM & Caribbean
Don't take our word for it
Singapore's regulator publishes a register of authorised products. Look up any supplier's claims yourself — including ours.
Verify a supplier

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us